Author(s): Smolen JS, Aletaha D
Remission should be the treatment aim in management of rheumatoid arthritis (RA) today because joint damage may progress in RA patients with low disease activity but presumably does not progress in patients in clinical remission. However, stringent criteria are needed to define remission status, as some criteria in current use allow for considerable residual disease activity. Even using stringent criteria, remission is achievable in a sizable proportion of patients in clinical trials and practice. Defining remission requires an additional consideration: Should a patient who is receiving medication be regarded as in remission if disease is absent, or must the patient be off treatment to be considered to be in remission? A case is made for aiming for a definition of remission that includes patients who continue medication therapy.
Referred From: https://www.ncbi.nlm.nih.gov/pubmed/17083756
Author(s): Maradit-Kremers H, Nicola PJ, Crowson CS, Ballman KV, Gabriel SE
Author(s): Hakoda M, Oiwa H, Kasagi F, Masunari N, Yamada M, et al.
Author(s): Suzuki A, Ohosone Y, Obana M, Mita S, Matsuoka Y, et al.
Author(s): Myllykangas-Luosujärvi R, Aho K, Kautiainen H, Hakala M
Author(s): Bakker MF, Jacobs JW, Verstappen SM, Bijlsma JW
Author(s): Choi HK, Hernán MA, Seeger JD, Robins JM, Wolfe F
Author(s): Toyoshima H, Kusaba T, Yamaguchi M
Author(s): Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, et al.
Author(s): Laakso M, Isomäki H, Mutru O, Koota K
Author(s): Lachmann HJ, Goodman HJ, Gilbertson JA, Gallimore JR, Sabin CA, et al.
Author(s): Matsuda Y, Singh G, Yamanaka H, Tanaka E, Urano W, et al.
Author(s): Yamanaka H, Tohma S
Author(s): Mutru O, Laakso M, Isomäki H, Koota K
Author(s): Wolfe F, Mitchell DM, Sibley JT, Fries JF, Bloch DA, et al.
